articleThe LancetJun 25, 2008GREEN OA

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial

Queen Mary University of London · Rambam Health Care Campus · +6 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,067
total citations
FWCI
58.20
Percentile
100%
References
39
Citations per year

Authors

10

Topics & keywords

Keywords
  • Medicine
  • Rivaroxaban
  • Pulmonary embolism
  • Venography
  • Enoxaparin sodium
  • Placebo
  • Deep vein
  • Surgery
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.